Toggle Main Menu Toggle Search

Open Access padlockePrints

Monocyte markers correlate with immune and neuronal brain changes in REM Sleep Behaviour Disorder

Lookup NU author(s): Professor David BrooksORCiD, Professor Nicola PaveseORCiD

Downloads


Licence

This is the authors' accepted manuscript of an article that has been published in its final definitive form by National Academy of Sciences, 2021.

For re-use rights please refer to the publisher's terms and conditions.


Abstract

Synucleinopathies are neurodegenerative diseases with both central and peripheral immune responses. However, whether the peripheral immune changes occur early in disease and their relation to brain events is yet unclear. Isolated rapid-eye-movement sleep behaviour disorder (iRBD) can precede synucleinopathy-related parkinsonism and provides a prodromal phenotype to study early Parkinson's disease events. In this prospective case-control study, we describe monocytic markers in a cohort of iRBD patients that were associated with the brain imaging markers of inflammation and neuronal dysfunction. Using 11C-PK11195 positron emission tomography (PET), we previously showed increased immune activation in the substantia nigra of iRBD patients, while 18F-DOPA positron emission tomography detected reduced putaminal dopaminergic function. Here we describe that patients’ blood monocytic cells showed increased expression of CD11b, while HLA-DR expression was decreased compared to healthy controls. The iRBD patients had increased classical monocytes and mature natural killer cells. Remarkably, the levels of expression of TLR4 on blood monocytes in iRBD patients were positively correlated with nigral immune activation measured by 11C-PK11195 PET and negatively correlated with putaminal 18F-DOPA uptake; - the opposite was seen for the percentage of CD163+ myeloid cells. This suggests a deleterious role for TLR4 and, conversely, a protective one for the CD163 expression. We show, for the first time, an association between peripheral blood monocytes and brain immune and dopaminergic changes in a synucleinopathy related disorder, thus suggesting a cross-talk between periphery and brain during the disease.


Publication metadata

Author(s): Farmen K, Nissen SK, Stokholm MG, Iranzo A, Østergaard K, Serradell M, Otto M, Svendsen KB, Garrido A, Vilas D, Borghammer P, Santamaria J, Møller A, Gaig C, Brooks DJ, Tolosa E, Pavese N, Romero-Ramos M

Publication type: Article

Publication status: Published

Journal: Proceedings of the National Academy of Sciences of the United States of America

Year: 2021

Volume: 118

Issue: 10

Print publication date: 09/03/2021

Online publication date: 09/03/2021

Acceptance date: 28/01/2021

Date deposited: 01/02/2021

ISSN (print): 0027-8424

ISSN (electronic): 1091-6490

Publisher: National Academy of Sciences

URL: https://doi.org/10.1073/pnas.2020858118

DOI: 10.1073/pnas.2020858118


Altmetrics

Altmetrics provided by Altmetric


Share